类有机物
肝星状细胞
肝细胞学
生物
基质凝胶
癌症研究
细胞培养
细胞生物学
血管生成
内分泌学
遗传学
肝脏代谢
作者
Yongdae Yoon,Seong Chan Gong,Moon Young Kim,Soon Koo Baik,Ju-Eun Hong,Ki‐Jong Rhee,Hoon Ryu,Young Woo Eom
出处
期刊:Cells
[Multidisciplinary Digital Publishing Institute]
日期:2023-10-24
卷期号:12 (21): 2514-2514
被引量:7
标识
DOI:10.3390/cells12212514
摘要
Liver organoids generated with single or multiple cell types have been used to investigate liver fibrosis development, toxicity, pathogenesis, and drug screening. However, organoid generation is limited by the availability of cells isolated from primary tissues or differentiated from various stem cells. To ensure cell availability for organoid formation, we investigated whether liver organoids could be generated with cell-line-based Huh-7 hepatocellular carcinoma cells, macrophages differentiated from THP-1 monocytes, and LX-2 hepatic stellate cells (HSCs) and primary liver sinusoidal endothelial cells (LSECs). In liver organoids, hepatocyte-, LSEC-, macrophage-, and HSC-related gene expression increased relative to that in two-dimensional (2D)-cultured Huh-7/LSEC/THP-1/LX-2 cells without Matrigel. Thioacetamide (TAA) increased α-smooth muscle actin expression in liver organoids but not in 2D-cultured cells, whereas in TAA-treated organoids, the expression of hepatic and LSEC markers decreased and that of macrophage and HSC markers increased. TAA-induced fibrosis was suppressed by treatment with N-acetyl-L-cysteine or tumor-necrosis-factor-stimulated gene 6 protein. The results showed that liver toxicants could induce fibrotic and inflammatory responses in liver organoids comprising Huh-7/LSEC/macrophages/LX-2 cells, resulting in fibrotic liver organoids. We propose that cell-line-based organoids can be used for disease modeling and drug screening to improve liver fibrosis treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI